Related Experiment Video
Updated: Jan 1, 2026

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.6K
An Automatic Assessment System for Alzheimer's Disease Based on Speech Using Feature Sequence Generator and Recurrent
Yi-Wei Chien1, Sheng-Yi Hong1, Wen-Ting Cheah1
1National Taiwan University, Department of Computer Science and Information Engineering, Taipei, Taiwan.
Scientific Reports
|December 22, 2019
Summary
Early detection of dementia is crucial. This study introduces an automated speech analysis system using recurrent neural networks for accessible cognitive assessment, achieving an AUC of 0.838.
Area of Science:
- Neurology
- Artificial Intelligence
- Speech Science
Background:
- Dementia, including Alzheimer disease, is a leading global cause of death.
- Early detection is vital for timely intervention due to the lack of a cure.
- Speech analysis offers a cost-effective and accessible method for cognitive assessment compared to medical imaging or blood tests.
Purpose of the Study:
- To develop an automated speech analysis system for early dementia detection.
- To propose a novel Feature Sequence representation for speech data.
- To utilize a data-driven approach for classification.
Main Methods:
- A novel Feature Sequence representation was developed for speech data.
- Recurrent neural networks (RNNs) were employed for automated classification.
- The system was designed for full automation and wide deployment.
Main Results:
- Experiments were conducted using 120 speech samples.
- The automated system achieved a high performance score.
- The area under the receiver operating characteristic curve (AUC) reached 0.838.
Conclusions:
- Automated speech analysis using RNNs and Feature Sequence representation is a promising tool for dementia detection.
- The system's automated nature facilitates widespread accessibility for public health.
- The high AUC score validates the effectiveness of this approach for cognitive assessment.
Related Concept Videos
Alzheimer's Disease: Overview
1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Alzheimer's Disease: Treatment
709
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
709

